2jnp
Solution structure of matrix metalloproteinase 3 (MMP-3) in the presence of N-isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid (NNGH)
|
OverviewOverview
We structurally characterized the adducts of the catalytic domain of, matrix metalloproteinase-3 (MMP3) with three different nonpeptidic, inhibitors by solving the solution structure of one adduct, [MMP3-N-isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid] and, then by calculating structural models of the other two adducts using a, reduced set of experimental NMR data, following a recently proposed, procedure (Bertini et al. in J. Med. Chem. 48:7544-7559, 2005). The, inhibitors were selected with the criteria of maintaining in all of them, the same zinc-coordinating moiety and of selectively changing the, substituents and/or the functional groups. The backbone dynamics on, various time scales have been characterized as well. The comparison among, these structures and with others previously reported allowed us to, elucidate fine details of inhibitor-receptor interactions and to develop, some criteria, which could guide in optimizing the design of selective, inhibitors.
About this StructureAbout this Structure
2JNP is a Single protein structure of sequence from Homo sapiens with , and as ligands. Active as Stromelysin 1, with EC number 3.4.24.17 Full crystallographic information is available from OCA.
ReferenceReference
Matrix metalloproteinase-inhibitor interaction: the solution structure of the catalytic domain of human matrix metalloproteinase-3 with different inhibitors., Alcaraz LA, Banci L, Bertini I, Cantini F, Donaire A, Gonnelli L, J Biol Inorg Chem. 2007 Nov;12(8):1197-206. Epub 2007 Aug 21. PMID:17710450
Page seeded by OCA on Wed Jan 23 11:42:26 2008